🇺🇸 POTASSIUM BICARBONATE in United States

1,332 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 181 reports (13.59%)
  2. Diarrhoea — 178 reports (13.36%)
  3. Nausea — 159 reports (11.94%)
  4. Dyspnoea — 140 reports (10.51%)
  5. Vomiting — 138 reports (10.36%)
  6. Fatigue — 135 reports (10.14%)
  7. Acute Kidney Injury — 124 reports (9.31%)
  8. Asthenia — 98 reports (7.36%)
  9. Headache — 92 reports (6.91%)
  10. Hypokalaemia — 87 reports (6.53%)

Source database →

POTASSIUM BICARBONATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is POTASSIUM BICARBONATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for POTASSIUM BICARBONATE in United States?

Marketing authorisation holder not available in our data.